Physician profile
Fred Mcalpin
NPI 1396812632
$14,554.63
in general payments reported to CMS, 2019-2025
22 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,820 · 2020: $1,730 · 2021: $1,053 · 2022: $1,710 · 2023: $1,871 · 2024: $3,411 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,938 · Food and Beverage: $3,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,938.25 |
| Food and Beverage | $3,302.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,018.58 | 2019-2025 | Mako, Gamma, Pangea |
| Eclipse Technology Solutions INC. | $3,864.24 | 2022-2025 | |
| Arthrex, INC. | $1,678.46 | 2022-2025 | Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Zimmer Biomet Holdings, INC. | $1,416.58 | 2019-2025 | Persona, Tapestry |
| Medical Device Business Services, INC. | $529.56 | 2019 | |
| Depuy Synthes Sales INC. | $500.01 | 2019-2025 | Na, Dynatape, Tfn-Advance |
| Smith+Nephew, INC. | $283.55 | 2022 | |
| Davol INC. | $257.17 | 2021-2024 | Arista Ah Flexitip |
| Prodigy Surgical Distribution, INC. | $219.63 | 2024 | |
| Miach Orthopaedics, INC. | $202.09 | 2023 | |
| Heron Therapeutics, INC. | $127.95 | 2022 | |
| Liberty Surgical INC. | $121.03 | 2021 | |
| Skeletal Dynamics INC | $72.56 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $64.02 | 2023 | Zilretta, Iovera, Exparel |
| Vericel Corporation | $48.50 | 2024 | Maci |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Bct, INC. | $42.28 | 2019 | |
| Molnlycke Health Care US, LLC | $29.73 | 2025 | Biogel Pi Ultratouch, Biogel Pi Indicator Underglove, Biogel Pi Orthopro |
| Nevro Corp. | $28.08 | 2019 | |
| Ossur Americas, INC. | $19.88 | 2024 | Miami J |
| Djo, LLC | $15.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.17 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$411,687.90 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Mcalpin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.